For the fourth consecutive year, growth in health care spending remained low, increasing by 3.7 percent in 2012 to $2.8 trillion. At the same time, the share of the economy devoted to health fell slightly (from 17.3 percent to 17.2 percent) as the nominal gross domestic product (GDP) grew by 4.6 percent. Faster growth in hospital services and in physician and clinical services was mitigated by slower growth in prices for prescription drugs and nursing home services. Despite an uptick in enrollment growth, Medicare spending growth slowed slightly in 2012, mainly due to lower payment updates. For Medicaid, slowing enrollment growth kept spending growth near historic lows. Growth in private health insurance spending also remained near historically low rates in 2012, largely influenced by the nation's modest economic recovery and its impact on enrollment.
T otal U.S. health care spending increased by 3.7 percent to S2.8 trillion (Exhibit 1), or $8,915 per person, in 2012. 1 Growth in national health spending has remained fairly stable since 2009, increasing between 3.6 per·ent and 3.8 percent annually. This low rate of increase followed a steady slowdown that began in 2003 after the most recent peak of9.7 percent in 2002. The relative stability since 2009 ~ il) reflects the lagged impacts of the recent severe e .. nomic 10n. In pamcu ar, income and emp oyment gro'> was modest over this period, and there was a slow recovery from private health insurance enrollment losses that oc-C\J rred during 2008-10. Gro!>s domestic product (GOP), which mea-.:-es the nation's overall economic output, ineased at approximately the same rate as did health spending in both 2010 and 2011. In 20 12 , nominal -that is, not adjusted for inflation-GOP gre, ... · almost 1 percentage point faster 1ian did health spending. As a result, the share of 1 "e economy devoted to health care in 2012 fell slightly from its 2011level (from 17.3 percent to 17.2 percent) (Exhibtt 2). For 2011 the health spending share of GDP was 0.6 percentage point lower than previously reported due to a large upward revision to GDP. ' The Affordable Care Act (ACA), which waL enactelHn .\\ arch 2010, had a minimal~ on-ovefali national h ealth spending grow!h,. tfuou h 201 . However, several proVisiOns imemented in 2010 and 2011 continued to affect the payers and programs that finan ced health care spending in 2012, including increased ~1ed icaid rebates for prescription drugs, the ~tedi care drug coverage gap ("doughnut hole") discount program, coverage for dependents under age twenty-six, and the minimum medical loss ratio provision. (The latter establishes the minimum amount of premium revenue that insurers must spend on medical claims and health care quality improvements.) 3 In 2012 a provision of the ACA reduced .:\1edicare payment updates for most providers, thereby contributing ro slower growth in .Medicare spending in 2012.
• IXHI B IT 1 National Health Expenditures (NHE), Aggregate And Per Capita Amounts, Share Of Gross Domestic Product (GOP) And Annual Growth, By Source Of Funds, Calendar Years 2007-12 ' Sourte of funds 1 t:nding, increased by 3.9 percent in 2012, only 0 4 percentage point faster than it grew in 2011 I xhibit 3). The remaining 15 percent of national ealth spending consists of health-related expenditures for public health activities, government administration and the net cost of health m urance, and investment in noncommercial rt'earch and m structures and equipment. In 201 2 slower growth in investment in healthrtlated equipment, a decline in noncommercial research due to the expiration of funding from the American Recovery and Reinvestment Act of 10119, and slower growth in the net cost of printe health insurance partially offset the faster gn:·wth in personal health care spending.
The uptick in personal health care spending •wth in 2012 was influenced primarily by hosnl services, for which spending increased 4 ~· percent in 2012 (compared to a 3.5 percent rrease in 2011) as a result of increased growth both nonprice factors (which include the use d intensity of services) and prices. Spending r physician and clinical services increased 4 6 percent in 2012 (from 4.1 percent growth -2011) and was the second-largest contributor the acceleration in personal health care spend· grov .. 1h. The faster growth in physician and cal services' spending was driven primarily ncreases in the volume and intensity of ser-.:s provided. ' Partially offsetting some of the increased ' 'th in spending for hospital care and physi-.;,un and clinical services in 2012 was slower growth in spending for prescription drugs and nursing home care. £rescription drug spending increased at a low rate of 0.4 percent in 2012,.
dmvn from 2.5 percent growth the prior year, mainly due to a slowdo\vn in price growth as an unusually large number of high-volume, high-cost drugs lost patent protection, which led to increased sales of lower-cost generics. Nursing home spending growth in 2012 slowed to . percent om . per n rn as i\1edi· ar uce payments for skilled nursing facilities to adjust for a large increase in payments that occurred in 2011.
Spending among health care payers varied in 2012, with faster growth in Medicaid and out-ofpocket spending, but slightly slower growth in private health insurance and Medicare spending. Medicaid spending growth (federal and state and local combined) remained relatively low but accelerated from 2.4 percent growth in 2011 to 3.3 percent in 2012 as some states withdrew previous payment cuts or expanded care (Exhibit 1).-Slightly faster growth in out-ofpocket spending (from 3.5 percent in 2011 to 3.8 percent in 2012) , largely attributable to increased cost sharing.' was evident in the accelerated growth for out-of-pocket spending for hospital and physician and clinical services. This growth was moderated by reduced out-of-pocket spending on prescription drugs that was influenced by the so-called patent cliff, or the wave of brand-name patent expirations that occurred in 2012, resulting in lower prices for previously expensive brand-name drugs.
Total private health insurance premiums grew 3.2 percent in 2012-the fifth consecutive year of low growth-in part as a result of the continued effects of the modest economic recovery on enrollment m pnvate health insurance plans. The movement of enrollees to high-deductible health plans, which typically have lower premiums and higher cost sharing, 9 also contributed to low growth in private health insurance premiums in 2012. ~tedicare growth slowed only slight!) (from 5.0 percent in 2011 to 4.8 percent in 2012} because of a one-time payment reduction for skilled nursing facilities as well as reduced feefor-service payment updates for hospitals and most other providers.
Factors Accounting For Growth
National health spending growth can be disaggregated into five broad factors: economywide inflation, medical-specific inflation, population change, shifts in the age and sex mix of the population, and other nonprice factors (which include changes in the use and intensity of services and errors in measuring prices or total spending). On a per capita basis, national health ' >pending increased 3.0 percent in 2012. Although per capita spending growth remained fairly stable in 2012, the factors underlying that growth were more varied.
\1edical price growth, which includes overall economywide inflation and medical-specific inflation, slowed to 1.7 percent in 2012 (from 2.4 percent growth in 20ll) and accounted for ,ust over half of the 3.0 percent increase in per .:apita health spending (Exhibit 4). This repreents a substantially smaller portion of health pending growth attributable to price growth compared to 2011, when pnce gro\Vth accounted fo r approximately 80 percent of overall per capita health spending growth (2.9 percent). The a\·ailability of lower-cost generic drugs and changes m .Medicare payments for nursing home and physician services contributed to this slower IX HIBIT 4 overall price growth. Nonprice factors include population growth (which has historically remained steady near 1.0 percent growth per year), demographic shifts in the population (also steady at approximately 0. 5 percent growth per year), and other nonpnce factors such as changes m the usc and intensity of services. After three years of historically low growth, growth in other nonprice factors rebounded in 2012 and accounted for roughly one-quarter of the 3.0 percent increase in per capita national health expenditures. Some of the increase in other nonprice factors was reflected m hospital services as well as in physician and clinical services.
Sponsors Of Health Care
As the main sponsors of health care, US households; private businesses; and federal, state, and local governments are responsible for financing the nation's health care bill. In 2012 households accounted for the largest share of spending (28 percent), followed by the federal government, private businesses, and state and local governments {E..xhlblt 5).
Household health spending includes out-of- Private health insuraQce (36 percent share) and Medicare (27 percent share) were the sourcs of payment for nearly two-thirds of all hospital .:are, and spending growth for both accelerated m 2012. Private health insurance payments to hospitals accelerated from 4.5 percent in 2011 to 58 percent in 2012, in part the result of a slight mcrease in the number of people covered by rrivate health insurance and faster growth in per enrollee spending for hospital services.
Medicare spending for hospital services in· creased by 4.5 percent rn 2012 compared to 3.6 percent in 2011, fueled by an influx of new enrollees, which also led to faster growth for other Medicare services. Partially offsetting this acceleration were provisions of the ACA that reduced growth in fee-for-servtce hospital payments.
Medicaid hospital spending also grew faster in 2012, increasing by 4.1 percent compared to 1.7 percent in 2011. However, gro\\.'th in Medicaid hospital spending during 2007-10 was much higher, averaging 7.3 percent annually. The higher grO\\.'th during this period was due to increased enrollment that occurred because of the recession as well as to enhanced federal funding mandated by the Amencan Recovery and Reinvestment Act of 2009. fn 2011, as the economy continued to improve, overall Medicaid enrollment growth slowed, and enhanced federal funding expired, contributing to slower hospital spending growth.
Physician And Clinical 'ic.rvicc Spending on total physician and clinical services grew by 4.6 percent in 2012 to $565.0 billion (Exhibit 3}. This rate was faster than in 2011, when spending grew by 4.1 percent. Although growth in pnces slowed slightly (from 1.4 percent in 2011 to 1.2 percent in 2012), 11 acceleration in the use and intensity of physician services contributed to faster overall physician spending growth. A recent study indicated that the number of office visits per day increased during much of 2012, notably for primary care providers.u Physician services, which accounted for 80 percent of physician and clinical services spending, grew by 4.0 percent in 2012, up from 3.5 percent in 2011. Spending for clinical services, which increased at a higher rate than spending for physician services for eight consecutive years, grew 7.1 percent in 2012 compared to 6.6 percent in 2011. Spending growth for clin:.. ical services has since 2005 been driven prim.ati; ly · by growth in spcndine for services at freestanding ambulatory surgical and emergency centers and kidney dialys1s cen$rS. As demand for'lower-cost and more convenient alternatives for care has increased in recent years, so, too, has the number of urgent care centers (including ambulatory surgical and emergency centers)}"'
Private health insurance and ,\1edicare accounted for the largest proportion of all physician and chnical servtces payments (just over two-thirds in 2012). Private health insurance and out-of-pocket payments for physician and clinical services increased at a faster rate in 2012 than in 2011, while growth in Medicare and Medicaid spending slowed. The growth in private health insurance spending was driven by increases in visits to doctors' offices as compared to the years immediately following the recession, which officially ended in June 2009. Medicare physician spendmg grov;th decelerated as a result of both slower growth m the volume and intensity of sel'Vlccs provided and a 0.0 percent payment update in 2012, which followed a 0.9 percent payment update m 2011.
Prescription Drugs
Total retail prescription drug spending grO\vth slowed in 2012, increasing by only 0.4 percent to $263.3 billion (compared to 2.5 percent growth in 2011; Exhibit 3). This reduced growth rate was driven largely by a slowdown in overall prices paid for retail prescription drugs as numerous brand-name blockbuster drugs (most notably Lipitor, Plavix, and Singulair} lost patent protection in late 2011 and in 2012 and as genenc versions became available. ' Strong growth in prices for specialty drugs, which are used to treat complex conditions and are typically more expensive than traditional brand-name drugs, moderated some of this slowdown.
• Prescription drug use p1cked up m 2012 as the number of dispensed prescriptions increased by 1.4 percent compared to 0.5 percent growth in 2011.
18 \1uch of this increased utilization was driven by the availability of lower-cost genenc drugs, which, for almost three-quarters of all dispensed prescriptions, cost $10 or less per prescription.
•~ The share of dispensed prescriptions that were generic (excluding branded generics) increased by almost 8 percentage points in 2012 (from 69.7 percent in 2011}. This is in contrast to annual increases in the generic dispensing rate of3 percentage points or less for 2009-11}~ Pnvate health insurance'· (44 percent share} and out-of-pocket paymenrs (18 percenr share) combined paid for almost two-thirds of all prescription drug spending in 2012. Spending for both of these payers declined in 2012, with private health insurance spending falling by 2.1 per cent and out-of-pocket paymenrs dropping 0.2 percent. These decreases resulted from private health insurance plans' continued movement to three-or four-tier comsurance or co payment structures, which charge less for generics and more for higher-cost drugs.~ These decreases are also attributable to the more popular and previously expensive blockbuster drugs' being available on a lower tier as generics.
Medicare alone is the second-largec;t contributor to total retail prescnption drug spending (26 percent share). Medicare's spending for prescription drugs continued to grow more quickly than did overall drug spending and increased by 7.9 percent in 2012 (compared to 7.3 percent in 2011}. 1 However, private health insurance enrollment was still 9.4 million lower in 2012 than it was in 2007; this declining enrollment was a major factor in the slow growth in overall private health insurance spending over the past several years. On a per enrollee basis, private health insurance premium growth remained persistently low in both 2011 and 2012, increasing by 2.8 percent and 2.7 percent, respectively. Per enrollee spending growtli for medical benefits accelerated slightly. from 2.9 percent in 2011 to 3.2 percent in 2012, both ncar historic lows.
Net enrollment gains in high-deductible plans contributed to the slow growth in premium~ Enrollmenr in high-deductible health plans, which generally have lower premiums and higher cost sharing than other more popular plans. accounted for 19 percenr of all covered workers and 31 percenr of the under-sixty-five insured population in 2012.' ··~'
The slightly faster rate of growth for private health insurance medical benefits in 2012 was Medicaid enrollment growth peaked in 2009 at 7.3 percent and slowed each year thereafter.
primarily due to increased growth in spending for hospital care and for physician and clinical services. These two services combined accounted for 72 percent of total private health insurance benefit spending in 2012. Partially offsetting the acceleration from these benefits was a 2.1 percent decline in private health insurance spending for retail prescription drugs (accounting for 15 percent of total private health insurance benefit spending), as several aforementioned blockbuster drugs moved to generic status.
The net cost of private health insurance, or the difference between premiums and benefits, remained relatively unchanged at $110 billion in 2012. However, because spending for medical benefits grew faster than did premiums, the net cost ratio, or the share of premiums attributed to nonmedical expenses, dropped from 12.4 percent in 2011 to 12.0 percent in 2012.
'1edicare
~1edicare accounted for 20 percent of national health spending in 2012, with expenditures reaching $572.5 billion (Exhibit 1). Overall, ~1edicare spending growth slowed slightly, increasing by 4.8 percent in 2012 compared to 5.0 percent in 2011. Growth in fee-for-service expenditures, which accounted for nearly threequarters of total Medicare spending, slowed from 4.3 percent in 2011 to 2.7 percent in 2012. Medicare Advantage spending accounted for the · remamder, mcreastng 10.9 percen · 2 1 -aster rate an 10 , w en growth was 7.~ent.
--errfOllmem in Medicare for all beneficiaries fee-for-service and Medicare Advantage) umped 4.1 percent in 2012-the largest one-year ncrease in enrollment in thirty-nine years-and more l!lan half of these enrollees igined Medi7~Advan~e. The noticeable increase in total e care enrollment reflected the oldest mem-"'ers of the baby-boom generation, who became eligible to enroll in Medicare in 2011.
Total Medicare spending per enrollee grew by 0. 7 percent in 2012-slower than the 2.5 percent rate of grovvth in 20ll. This slowdown was largely due to a prominent decline in spending for nursing home care, which declined by 2.2 percent in 2012 following an increase of9.9 percent the year before. This in tum was driven primarily by a one-time payment reduction to skilled nursing facilities, which followed a large increase in payments in 20ll corresponding to the introduction of the new payment system. In 2012 this reduction was applied to skilled nursing facility rates to recalibrate payments for the newly implemented payment system.
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For Medicare fee-for-service, per enrollee spending growth decelerated from 2. 7 percent in 2011 to 0.6 percent in 2012. In addition to the decline in skilled nursing facility spending, slower growth in fee-for-service spending was influenced by spending trends for prescription drugs, physician and clinical services, and hospital care. For beneficiaries with traditional feefor-service Medicare, prescription drug spending growth slowed because of the increased use of popular lower-cost generic drugs. Slower growth in the volume and intensity of physician services and inpatient hospital admissions contributed to slower fee-for-service Medicare physician and hospital spending in 2012. Finally, for all Part A and most Part B providers, the ACA reduced payment updates in 2012, most notably for hospitals.
The acceleration in Medicare Advantage spending growth in 2012 was driven by a 10.0 percent increase in enrollment. On a per e ee basis, however, Medicare Advantage spendin rowth s owe to n 10 201 (from16~~cent~rowthin2011),partia ly asa result afthdAt~kmeptation of the ACA's newPa'ymentmechanislJl.. That mechanism links ) benchmark payment rates to fee-for-service costs, and its implementation effectively lowered the increase in total Medicare Advantage payments. In addition, the ACA required quality ratings of plans to factor into payments beginning in 2012.
.Medicaid
Medicaid spending by both federal and state governments reached $421.2 billion in 2012, accounting for 15 percent of total national health expenditures (Exhibit 1). Medicaid spending increased by 3.3 percent in 2012, following a low 2.4 percent growth rate in 2011. These were the two slowest annual rates of growth in the history of Medicaid (excluding 2006, when Medicare Part D was implemented, changing the way Medicaid paid for some beneficiaries' prescription drugs). These growth rates were due primarily to slower enrollment growth and to efforts by states to control costs following the expiration of enhanced federal matching rates. ' Since For the second year in a row, the federal government's portion of Medicaid spending declined ( 4.2 percent reduction in 2012 and 7.2 percent reduction in 2011), largely because of the expiration of the enhanced federal matching rates. These enhanced matching rates caused the share of Medicaid financed by the federal government to increase to approximately 67 percent in 2010. In 2012 this share fell to 56 percem., similar to its share immediately before the recent rec~Concurrently, state and local ~1edicaid spending increased substantially (from just 2.7 percent growth in 2010, to 22.0 percent in 2011, and 15.0 percent in 2012) . This increase reflects the end of additional funding from the American Recovery and Reinvestment Act of 2009.
Conclu~ion
In 2012 the economy continued to modestly improve, and GOP grew faster than health care spending. causing the health spending share of the economy to fall slightly-from 17.3 percent to 17.2 percent. Spending growth for personal health care goods and services accelerated in 2012 as trends for hospital services and physician and clinical services more than offset onetime impacts that helped decelerate growth, such as numerous patent expirations for brand-name retail prescription drugs and a Medicare payment reduction for skilled nursing facilities. From a payer perspective, Medicaid spending growth accelerated somewhat in 2012 after experiencing low growth in 2011, while Medicare and private health insurance spending grov.rth slowed slightly. These mixed trends produced the fourth consecutive year of low overall health spending growth and led to a relatively stable health spending share of GOP. However, this pattern is consistent with historical experience when health spending as a share of GOP often stabilizes approximately two to three years after the end of a recession and then mcreases when the economy significantly improves. Recently, however, the question has arisen about whether a more fundamental change is occurring within the health sector and whether this stability will endure. From our perspective, more historical evidence is needed before concluding that we have observed a structural break in the historical relationship between the health sector and the overall economy. • 
